Pharmacotherapy of pediatric HIV infection
- PMID: 23036246
- PMCID: PMC3465562
- DOI: 10.1016/j.pcl.2012.07.009
Pharmacotherapy of pediatric HIV infection
Abstract
The delivery of safe and effective antiretroviral therapy to children and adolescents is crucial to save the lives of millions of children worldwide. The immunologic response to human immunodeficiency infection is closely related to a child's development and creates age-specific parameters for the evaluation of therapeutic response to antiretroviral therapy. Similarly, the development and maturation of organ systems involved in drug absorption, distribution, metabolism, and elimination determines significant changes in the pharmacokinetics of antiretroviral drugs throughout childhood. The authors review the evolution in treatment of pediatric HIV from infancy through adolescence.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Antiretroviral pharmacology: special issues regarding pregnant women and neonates.Clin Perinatol. 2010 Dec;37(4):907-27, xi. doi: 10.1016/j.clp.2010.08.006. Clin Perinatol. 2010. PMID: 21078458 Review.
-
Escalating and sustained immunovirological dissociation among antiretroviral drug-experienced perinatally human immunodeficiency virus-1-infected children and adolescents living in the Central African Republic: A STROBE-compliant study.Medicine (Baltimore). 2020 May 22;99(21):e19978. doi: 10.1097/MD.0000000000019978. Medicine (Baltimore). 2020. PMID: 32481261 Free PMC article.
-
Antiretroviral therapy and mother-to-child transmission of HIV-1.Expert Rev Anti Infect Ther. 2004 Oct;2(5):717-32. doi: 10.1586/14789072.2.5.717. Expert Rev Anti Infect Ther. 2004. PMID: 15482235 Review.
-
Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.N Engl J Med. 2004 Jul 15;351(3):289-92. doi: 10.1056/NEJMe048128. Epub 2004 Jul 9. N Engl J Med. 2004. PMID: 15247337 No abstract available.
-
Pharmacokinetic considerations of perinatal antiretroviral therapy.Curr Drug Metab. 2012 Jul;13(6):744-59. doi: 10.2174/138920012800840365. Curr Drug Metab. 2012. PMID: 22452457 Review.
Cited by
-
Trends in Diagnoses Among Hospitalizations of HIV-infected Children and Adolescents in the United States: 2003-2012.Pediatr Infect Dis J. 2017 Oct;36(10):981-987. doi: 10.1097/INF.0000000000001645. Pediatr Infect Dis J. 2017. PMID: 28640002 Free PMC article.
-
HIV-1 proteins, Tat and gp120, target the developing dopamine system.Curr HIV Res. 2015;13(1):21-42. doi: 10.2174/1570162x13666150121110731. Curr HIV Res. 2015. PMID: 25613135 Free PMC article. Review.
References
-
- World Health Organization. [Accessed May 17, 2012];Global summary of the HIV/AIDS epidemic. 2010 Dec; Available at: http://wwwwhoint/hiv/data/en/
-
- Connor E, McSherry G. Treatment of HIV infection in infancy. Clin Perinatol. 1994;21(1):163–77. Epub 1994/03/01. - PubMed
-
- World Health Organization. Antiretroviral therapy of HIV Infection in infants and children: towards universal access: recommendations for a public health approach-2010 revision. WHO; Geneva: 2010. - PubMed
-
- Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. [Accessed May 01, 2012];Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Updated August 11, 2011. Available at http://aidsinfo.nih.gov/contentfiles/PediatricGuidelines.pdf.
-
- Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services; [Accessed May 11, 2012]. Updated March 27, 2012. http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical